102-wk clinical and radiologic results from the ATTRACT trial : a 2 year, randomized, controlled, phase 3 trial of infliximab (Remicade) in pts with active RA despite MTX

収録刊行物

• Arthritis Rheum

  Arthritis Rheum 43 (0), 2000